Glucosamine 500 mg
Natural health product licensed in Canada
- Other names
- Glucosamine Sulfate, Glucosamine Sulfate 500 mg
- Licence holder
- Les Laboratoires Suisse Inc.
- NPN or DIN-HM
- 80000279
- Status
- Inactive licence
- Licence date
- 20 January 2005
- Revision date
- 15 August 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Cellulose - microcrystalline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
2Contribue à soulager les symptômes ostéoarthritiques. Joue un rôle dans les maintien du cartilage. Protège contre la détérioration du cartilage résultant des maladies chroniques des articulations. Est efficace dans la réduction de la douleur articulaire.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé avant l'utilisation si vous souffrez du diabète. Consulter un praticien de soins de santé si les symptômes persistent.
- Contre-indications
A éviter en cas d' allergies aux mollusques. Ne pas utiliser en cas de grossesse ou d'allaitment.
Source
Official Health Canada record, licence 80000279
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging